American International Group, Inc. Reata Pharmaceuticals Inc Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$79.22 - $105.37 $32,717 - $43,517	413 Added 3.1%	13,757 $1.4 Million
Q1 2023 May 12, 2023	BUY	$30.85 - $93.17 $8,175 - $24,690	265 Added 2.03%	13,344 $1.21 Million
Q4 2022 Feb 10, 2023	SELL	$22.15 - $42.11 $1,041 - $1,979	-47 Reduced 0.36%	13,079 $496,000
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $3,590 - $6,750	185 Added 1.43%	13,126 $330,000
Q2 2022 Aug 12, 2022	SELL	$20.71 - $36.5 $14,289 - $25,185	-690 Reduced 5.06%	12,941 $393,000
Q1 2022 May 13, 2022	SELL	$24.12 - $39.6 $23,131 - $37,976	-959 Reduced 6.57%	13,631 $447,000
Q4 2021 Feb 11, 2022	SELL	$25.61 - $110.96 $11,191 - $48,489	-437 Reduced 2.91%	14,590 $385,000
Q3 2021 Nov 12, 2021	SELL	$100.0 - $143.02 $35,700 - $51,058	-357 Reduced 2.32%	15,027 $1.51 Million
Q2 2021 Aug 13, 2021	BUY	$78.27 - $151.29 $1.16 Million - $2.24 Million	14,826 Added 2656.99%	15,384 $2.18 Million
Q1 2021 May 07, 2021	SELL	$94.25 - $132.81 $1,413 - $1,992	-15 Reduced 2.62%	558 $56,000
Q4 2020 Feb 12, 2021	SELL	$102.03 - $184.62 $2,346 - $4,246	-23 Reduced 3.86%	573 $71,000
Q3 2020 Nov 04, 2020	SELL	$93.53 - $163.34 $1,590 - $2,776	-17 Reduced 2.77%	596 $58,000
Q2 2020 Aug 12, 2020	SELL	$126.3 - $176.56 $1.62 Million - $2.26 Million	-12,801 Reduced 95.43%	613 $96,000
Q1 2020 May 04, 2020	SELL	$124.16 - $247.74 $73,378 - $146,414	-591 Reduced 4.22%	13,414 $1.94 Million
Q4 2019 Feb 05, 2020	BUY	$74.57 - $217.92 $97,761 - $285,693	1,311 Added 10.33%	14,005 $2.86 Million
Q3 2019 Nov 08, 2019	SELL	$71.26 - $95.75 $6,270 - $8,426	-88 Reduced 0.69%	12,694 $1.02 Million
Q2 2019 Aug 13, 2019	BUY	$77.72 - $94.35 $56,735 - $68,875	730 Added 6.06%	12,782 $1.21 Million
Q1 2019 May 06, 2019	SELL	$51.9 - $101.79 $13,390 - $26,261	-258 Reduced 2.1%	12,052 $1.03 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $76.44 $4,583 - $7,185	-94 Reduced 0.76%	12,310 $691,000
Q3 2018 Nov 09, 2018	BUY	$35.64 - $92.06 $72,848 - $188,170	2,044 Added 19.73%	12,404 $1.01 Million
Q2 2018 Aug 08, 2018	BUY	$19.94 - $40.96 $62,372 - $128,122	3,128 Added 43.25%	10,360 $362,000
Q1 2018 May 07, 2018	SELL	$20.0 - $30.19 $7,800 - $11,774	-390 Reduced 5.12%	7,232 $148,000
Q4 2017 Feb 09, 2018	BUY	$22.39 - $33.27 $2,104 - $3,127	94 Added 1.25%	7,622 $216,000
Q3 2017 Nov 09, 2017	BUY	$26.29 - $31.88 $197,911 - $239,992	7,528	7,528 $234,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account